How Home Delivery of Antiretroviral Drugs Ensured Uninterrupted HIV Treatment During COVID-19: Experiences From Indonesia, Laos, Nepal, and Nigeria

Figures & Tables

Download figure
Open in new tab
Download powerpoint
Discreet packaging of antiretroviral drugs in Jakarta, Indonesia. © 2020 Ade Sonyville and Arifin Fitrianto/LINKAGES/FHI 360 Indonesia
Download figure
Open in new tab
Download powerpoint
Outreach worker on the way to delivering antiretroviral drugs to clients at their homes in Nepal. © 2020 NAMUNA/LINKAGES/FHI 360
Download figure
Open in new tab
Download powerpoint
A community pharmacist boards at the jetty with supplies for clients along remote creeks in Akwa Ibom State, Nigeria. © 2020 Otoyo Toyo/AHNI

TABLE.

Summary of Antiretroviral Drug Home Delivery Interventions in 4 Countries

	Nigeria	Indonesia	Nepal	Laos
Implementation period reported	May–Nov 2020	Apr–Nov 2020	Mar–Sep 2020	May–Sep 2020
Client groups^{^a}	General population/rural population	Key populations, their partners and children, and other priority populations	Female sex workers, MSM, transgender people, and migrants and their spouses	MSM/transgender people and their partners who are living with HIV
No. of facilities participating in home delivery	21	109	19	3
Recommended frequency of clinical consultation for established ART clients	Every 6 months	Every 6 months	Every 6 months	Every 6 months
Recommended frequency of viral load testing for established ART clients	Every 6 months	Every 12 months	Every 12 months	Every 6 months (for first year) and every 12 months for year 2 onward
Modification for viral load testing during the COVID-19 pandemic	Sample collection in the community	Transport of samples to private laboratories	Sample collection in the community	No change: facility-based collection required
Clients who received home delivery, n (% of eligible for home delivery)	4,138 (51)	4,948 (19)	2,836 (21)	126 (26)